Trump Administration Halts H.I.V. Drug Distribution in Poor Countries

trump-administration-halts-hiv.-drug-distribution-in-poor-countries

You have a preview view of this article while we are checking your access. When we have confirmed access, the full article content will load.

PEPFAR’s computer systems also are being taken offline, a sign that the program may not return, as Republican critics had hoped.

A view inside an AIDS clinic, with large cardboard boxes of medications being tended to by a worker in a red shirt and white hat.
A shipment of medications in an AIDS clinic in Johannesburg. The freeze means many people with H.I.V. are facing abrupt interruptions to their treatment, even if the drugs have already been obtained and are sitting in local clinics awaiting distribution.Credit…Foto24/Gallo Images, via Getty Images

Apoorva Mandavilli

The Trump administration has instructed organizations in other countries to stop disbursing H.I.V. medications purchased with U.S. aid, even if the drugs have already been obtained and are sitting in local clinics.

The directive is part of a broader freeze on foreign aid initiated last week. It includes the President’s Emergency Plan for AIDS Relief, the global health program started by George W. Bush that is credited with saving more than 25 million lives worldwide.

The administration had already moved to stop PEPFAR funding from moving to clinics, hospitals and other organizations in low-income countries.

Appointments are being canceled, and patients are being turned away from clinics, according to people with knowledge of the situation who feared retribution if they spoke publicly. Many people with H.I.V. are facing abrupt interruptions to their treatment.

But most federal officials are also under strict orders not to communicate with external partners, leading to confusion and anxiety, according to several people with knowledge of the situation.

U.S. officials have also been told to stop providing technical assistance to national ministries of health.


Thank you for your patience while we verify access. If you are in Reader mode please exit and log into your Times account, or subscribe for all of The Times.


Thank you for your patience while we verify access.

Already a subscriber? Log in.

Want all of The Times? Subscribe.

Leave a Reply

Your email address will not be published. Required fields are marked *